molecalculator

Moles & Molar Mass

mRNA Technology: Who Invented It?

Guide 01-11631 · Updated · Step by step

mRNA technology was not invented by a single person; it is the result of decades of collaborative research by many scientists, with key contributions from Katalin Karikó and Drew Weissman, whose 2005 discovery of modified nucleosides made therapeutic mRNA viable. This breakthrough, which earned them the 2023 Nobel Prize in Physiology or Medicine, built on earlier work in the 1960s and 1970s that first isolated and described messenger RNA. The technology was later developed into vaccines by companies like Moderna and BioNTech, but the core invention is a shared scientific achievement.

Early Foundations: The Discovery of mRNA

Messenger RNA (mRNA) was first discovered in 1960 by Sydney Brenner, François Jacob, and Matthew Meselson, who identified a short-lived RNA molecule that carries genetic instructions from DNA to ribosomes, where proteins are made. In 1961, Jacob and Jacques Monod proposed the concept of mRNA as the intermediary between genes and proteins. These discoveries were purely basic science—no one imagined mRNA could be used as a drug. The molecule was known to be fragile, quickly degraded inside cells, and triggered strong immune responses, making it seem useless for therapy.

How mRNA Therapy Works

Therapeutic mRNA is a synthetic copy of a gene’s coding sequence. When introduced into cells, it uses the cell’s own protein-making machinery to produce a specific protein. For vaccines, that protein is a harmless piece of a pathogen (like the spike protein of SARS-CoV-2), which trains the immune system to recognize and attack the real virus. The mRNA is packaged in lipid nanoparticles (LNPs) to protect it from enzymes and help it enter cells. Once inside, the mRNA is translated, the protein is made, and the mRNA is naturally degraded—it never enters the nucleus and does not integrate into DNA.

Key Breakthroughs: Modified Nucleosides and Delivery

The biggest hurdle was that synthetic mRNA caused severe inflammation when injected. In 2005, Katalin Karikó and Drew Weissman at the University of Pennsylvania discovered that substituting uridine with pseudouridine (a naturally occurring modified nucleoside) in mRNA prevented activation of the innate immune sensor TLR3, reducing inflammation and increasing protein production. This was the single most important step in making mRNA therapeutically useful. Later, advances in lipid nanoparticle delivery, pioneered by researchers like Pieter Cullis and others, allowed mRNA to survive in the bloodstream and enter cells efficiently—without LNPs, the mRNA would be destroyed before reaching its target.

From Lab to Vaccine: The COVID-19 Race

Before 2020, mRNA vaccines had been tested in clinical trials for rabies, Zika, and cytomegalovirus, but none had been approved. When the SARS-CoV-2 virus emerged, both Moderna (using technology licensed from the University of Pennsylvania) and BioNTech (in partnership with Pfizer) rapidly developed mRNA vaccines. The vaccines were authorized in December 2020, just 11 months after the viral sequence was published. This unprecedented speed was possible because the mRNA platform is fully synthetic—no need to grow virus or handle infectious agents—and because the modified nucleoside technology was already proven safe in earlier trials.

Common Misconceptions

A frequent myth is that mRNA vaccines alter your DNA. They do not: mRNA stays in the cytoplasm, never enters the nucleus, and has no enzyme to integrate into chromosomes. Another misconception is that mRNA technology was invented in 2020—it was not; the fundamental science is over 60 years old. Some people also confuse mRNA with gene therapy, but gene therapy delivers DNA to permanently change cells, while mRNA is transient and degrades after a few days. The 2005 Karikó–Weissman discovery is often called the “invention” because without it, mRNA caused too much inflammation to be used safely.

Costs and Manufacturing

mRNA production is cheaper and faster than traditional vaccine manufacturing because it does not require cell cultures or fermentation of live viruses. The raw materials—nucleotides, enzymes, and lipids—are relatively inexpensive, but the process requires strict cold-chain storage (mRNA vaccines need temperatures around -20°C to -70°C) and specialized facilities. A typical mRNA vaccine dose costs a few dollars to manufacture, but development and clinical trials are expensive, which is why initial prices are higher. As the technology matures, costs are expected to drop, making mRNA vaccines affordable for low-income countries.

Safety and Side Effects

mRNA vaccines have been given to billions of people, and their safety profile is well established. Common side effects include pain at the injection site, fatigue, headache, and fever, which are signs of the immune response. Serious adverse events are rare: anaphylaxis occurs in about 5 cases per million doses, and myocarditis (heart inflammation) is seen mainly in young males, with most cases resolving quickly. Long-term effects are unlikely because mRNA degrades within days, and the protein it encodes is cleared from the body. The technology is not new—it has been studied for over two decades, and no unexpected long-term safety signals have emerged.

Alternatives and Future Uses

mRNA is not the only vaccine platform—traditional inactivated vaccines, protein subunit vaccines, and viral vector vaccines (like the Johnson & Johnson COVID-19 vaccine) are alternatives. However, mRNA offers advantages: rapid design, high efficacy, and easy modification for new variants. Beyond vaccines, mRNA technology is being tested for cancer immunotherapy (teaching immune cells to attack tumors), protein replacement therapy (e.g., for rare enzyme deficiencies), and even gene editing (delivering mRNA for CRISPR proteins). The same modified nucleoside and LNP delivery platform is the foundation for all these applications.

Frequently Asked Questions

Who exactly invented mRNA vaccines?

No single person invented the mRNA vaccine. The concept of mRNA therapy dates back to the 1970s, but the key enabling discoveries were made by Katalin Karikó and Drew Weissman (modified nucleosides, 2005) and by researchers who developed lipid nanoparticle delivery, such as Pieter Cullis. The COVID-19 vaccines were developed by teams at Moderna and BioNTech/Pfizer, building on these earlier contributions.

Did the COVID-19 vaccine use new technology?

Yes, it was the first time an mRNA vaccine was approved for human use, but the underlying technology had been in development for over 15 years. Clinical trials for mRNA vaccines against other diseases were already underway before 2020, so the platform was not new—only the specific vaccine was new.

Can mRNA change your DNA?

No. mRNA cannot enter the nucleus, and it does not contain the enzyme (integrase) needed to insert into DNA. It is translated into protein in the cytoplasm and then degraded. Studies have confirmed no integration into the human genome.

How long does mRNA stay in your body?

mRNA is broken down within a few days after injection. The lipid nanoparticles are cleared by the liver, and the mRNA is degraded by normal cellular enzymes. The protein it produces may last a bit longer, but the mRNA itself is short-lived.

Are mRNA vaccines safe for pregnant people?

Yes, multiple studies have shown that mRNA COVID-19 vaccines are safe during pregnancy, with no increased risk of miscarriage or birth defects. The vaccines do not cross the placenta in significant amounts, and they provide protection for both mother and baby.

What are the risks of myocarditis from mRNA vaccines?

Myocarditis (heart inflammation) is a rare side effect, most common in males under 30, usually within a week after the second dose. The rate is about 1 in 10,000 to 1 in 50,000 doses, and most cases are mild and resolve with rest and medication. The risk of myocarditis from COVID-19 infection itself is much higher.

Related

General steps for current mainstream versions; menus can differ by device and version. See the disclaimer or report an error.

More in this section

The whole Moles & Molar Mass section →